Research programme: benzopyran-based therapeutics - Kazia Therapeutics/Genea Biocells

Drug Profile

Research programme: benzopyran-based therapeutics - Kazia Therapeutics/Genea Biocells

Alternative Names: GBC - 0905; Super-benzopyran compounds - Kazia Therapeutics/Genea

Latest Information Update: 28 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genea Biocells; Novogen
  • Developer Genea Biocells; Kazia Therapeutics
  • Class Benzopyrans; Small molecules
  • Mechanism of Action DUX4 protein inhibitors; Electron transport chain complex protein inhibitors; Stem cell modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Facioscapulohumeral muscular dystrophy
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Brain injuries
  • No development reported Alzheimer's disease; Amyotrophic lateral sclerosis; Brain disorders; Facioscapulohumeral muscular dystrophy; Mucopolysaccharidosis III

Most Recent Events

  • 28 Jun 2018 No recent reports of development identified for preclinical development in Alzheimer's-disease in Australia (Parenteral)
  • 28 Jun 2018 No recent reports of development identified for preclinical development in Amyotrophic-lateral-sclerosis in Australia (Parenteral)
  • 28 Jun 2018 No recent reports of development identified for preclinical development in Brain-disorders in Australia (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top